BTA-9881

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBTA-9881
Drug Alias NameBTA-9881AZD-9639MEDI-564
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionViral fusion proteins inhibitors
TargetsViral fusion proteins
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAviragen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A